Patients in the thrombus resolution group had a higher prevalence of previous heart failure, lower LVEF and higher levels of N-Terminal pro-Brain Natriuretic Peptide (NT-proBNP), a smaller baseline thrombus, a higher proportion of spontaneous echo contrast, and a lower incidence of regional wall motion abnormality and ventricular aneurysm (Table 2). The gene discussed is NPPB; the disease is heart failure.